Skip to main content
Caplight Logo









Optheras A/S

Optheras A/S

Private
BirkerødHealthcare & Life Scienceshttps://optheras.com/

Last Round

Grant

May 27, 2026

Total Funding Raised

$6M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Optheras A/S is a medical technology company that develops an innovative laser platform for the outpatient treatment of superficial bladder cancer.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

medical laserbladder cancer treatmentnon-muscle invasive bladder cancerNMIBCurologyoutpatient surgerylaser ablationmedtechsurgical roboticstransurethral resection of bladder tumorsTURBTclinical trialsFDA breakthrough deviceminimally invasive surgeryAI-guided surgery

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Optheras A/S Comparables

Compare Optheras A/S with similar companies based on industry and business-model similarity.

Optheras A/S comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Vessi Medical
81%
CAPS Medical
81%
Combat Medical
70%

Optheras A/S Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMay 27, 2026
SeedAug 26, 2025
AngelJun 1, 2022

Key People

Founding team and executive leadership

Thomas Alkeskjold

Co-founder and CEO

Founding Team

Optheras A/S Investors

Notable investors and investment history

Optheras A/S investors
InvestorRounds
MedTech InnovatorGrant
T&W MedicalAngel, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 27, 2026

    Received grant funding from MedTech Innovator.

  • Mar 9, 2026

    Grew 20% QoQ, from 20 to 24 employees.

Optheras A/S Filings

Explore SEC and related filing metadata, where available.

Optheras A/S filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Optheras A/S's valuation, stock price, and market status.

Is Optheras A/S a public or private company?

Optheras A/S is a private company.

What is the current stock price of Optheras A/S?

Optheras A/S is a private company with no public stock price. No recent secondary market data is available.

How much is Optheras A/S worth (valuation)?

Valuation information for Optheras A/S is not publicly available.

Can I buy Optheras A/S stock?

Optheras A/S shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Optheras A/S's last funding round?

Optheras A/S's most recent funding round was Grant on May 27, 2026.

Who are the main investors in Optheras A/S?

Key investors in Optheras A/S include MedTech Innovator, T&W Medical.

Will Optheras A/S IPO soon?

No public IPO plans have been announced for Optheras A/S.

How can I track Optheras A/S secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Optheras A/S's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBirkerød
Employee Range26
Year Founded2021
Last FundingMay 27, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?